GeoVax Labs Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About GeoVax Labs Inc
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company’s key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy GeoVax Labs Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for GeoVax Labs Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for GeoVax Labs Inc is GOVX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
GeoVax Labs Inc has its primary listing on NASDAQ (Small cap). You can trade GeoVax Labs Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, GeoVax Labs Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include GeoVax Labs Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like GeoVax Labs Inc.